The bispecific antibody therapeutics market is estimated to be worth USD 6.9 billion in 2030

5
health-fitness

Summary

The study features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain.

Press Release

Bispecific antibody therapeutics represent a transformative approach to modern treatment; over the years, this upcoming class of ‘two-target’ artificially engineered drugs have generated significant enthusiasm within the medical science community

 

Roots Analysis is pleased to announce the publication of its recent study, titled, “Bispecific Antibody Therapeutics Market (4th Edition), 2020-2030.”

 

For more Insightful information please click on link:

https://www.rootsanalysis.com/reports/view_document/bispecific-antibodies/286.html

 

 

To request a sample report – https://www.rootsanalysis.com/reports/286/request-sample.html

 

  • Target Antigens
  • CD3 x CD19
  • CD30 x CD16A
  • Factor IXa x Factor X
  • IL-1α x IL-1β
  • IL-13 x IL-4
  • IL-17A x Albumin
  • IL-17A x IL-17F
  • Psl x PcrV
  • TNF-α x HAS
  • VEGF-A x ANG2
  • Others
  • Antibody Format
  • Asymmetric
  • Fragments
  • Symmetric
  • Others
  • Key Geographical Region
  • North America
  • Europe
  • Asia-Pacific

 

Transcripts of interviews held with the following senior level representatives of stakeholder companies:

  • Martin Steiner (Chief Executive Officer, Synimmune)
  • Ludger Große-Hovest (Chief Scientific Officer, Synimmune)
  • Jane Dancer (Chief Business Officer, F-Star)
  • Siobhan Pomeroy (Senior Director, Business Development, Cytom X)
  • Yinjue Wang (Associate Director, Process Development, Innovent Biologics)

 

To request a customize report – https://www.rootsanalysis.com/reports/bispecific-antibodies/request-customization.html

 

Key companies covered in the report

  • Amgen
  • Ablynx
  • AbbVie
  • Affibody
  • Affimed
  • Alphamab
  • AstraZeneca
  • Avillion
  • Chugai Pharmaceuticals
  • Eddingpharm
  • GSK
  • Merck
  • Merus
  • Roche
  • Regeneron Pharmaceuticals
  • Taisho Pharmaceuticals
  • Zymeworks

 

For more information please click on the following link:

https://www.rootsanalysis.com/reports/view_document/bispecific-antibodies/286.html

 

Other Recent Offerings

  1. Global Preventive Vaccines Market, 2020-2030
  2. Endocannabinoid System Targeted Therapeutics Market, 2019-2030
  3. Antibody Contract Manufacturing Market, 2020-2030
  4. Cloud-based Solutions for Drug Discovery, Development and Manufacturing Market
  5. Dravet Syndrome Market
  6. Alpha-1 Antitrypsin Deficiency (AATD)

 

About Roots Analysis

Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at [email protected]

 

Contact Information

Roots Analysis Private Limited

Gaurav Chaudhary

+1 (415) 800 3415

[email protected]

Facebook – https://www.facebook.com/RootsAnalysis

LinkedIn – https://www.linkedin.com/company/roots-analysis/mycompany/

Twitter – https://twitter.com/RootsAnalysis